Barbara Ewals: SIOG is proud to be a consortium partner of the Definitive Project
“Exciting news!
SIOG (International Society of Geriatric Oncology) is proud to be a consortium partner of the Definitive Project, a groundbreaking clinical trial funded by the European Commission.
This project is focused on demonstrating the impact of personalized treatment decisions in early-stage HER2-positive breast cancer using the innovative HER2DX® diagnostic assay.
The goal? To improve quality of life without compromising outcomes or survival rates while proving the safety, efficacy and cost-effectiveness of HER2DX® for hospitals and public health systems
At SIOG, we are committed to advancing precision oncology and improving care for older adults with cancer. We are thrilled to contribute to this vital initiative!”
More posts featuring SIOG.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023